乳腺癌患者影像学二次会诊对临床的影响
该回顾性研究纳入2016年7月至2017年3月在一家美国国家癌症研究所指定的综合癌症中心进行乳腺癌诊断后二次会诊的252例患者,比较院外与二次会诊的乳腺影像报告,发现16%的病例存在显著判读差异,导致15%的病例需额外检查、7.1%的病例临床管理改变、4.4%的病例发现额外恶性肿瘤或更大范围病变。
要点
- 16%的乳腺癌患者院外与二次会诊乳腺影像判读存在显著差异(评分3或4分)。
- 15%的病例因判读差异需额外检查,7.1%的病例临床管理改变,6.0%手术管理改变。
- 4.4%的病例因二次会诊发现额外恶性肿瘤或更大范围病变。
核心结论
- 院外与二次会诊乳腺影像亚专科医生之间的判读差异常导致乳腺癌患者接受额外检查、治疗计划改变以及发现新的恶性肿瘤。
研究设计与样本
- 经机构审查委员会批准的回顾性研究,纳入2016年7月至2017年3月在一家美国国家癌症研究所指定的综合癌症中心因乳腺癌诊断后二次会诊的患者252例,随机选取,由两位乳腺亚专科放射科医生将院外与二次会诊报告与共识进行比较。
诊断标准与关键数值
- 采用模仿ACR RADPEER™同行评审指标的评分:1分为同意;2分为轻微差异(不太可能有临床意义);3分为中度差异(可能有临床意义);4分为重大差异(可能有临床意义)。
- 判读显著差异(评分3或4分)见于41/252例(16%,95%CI 11.7%-20.8%)。
- 判读差异导致额外检查38/252例(15%,95%CI 10.6%-19.5%)。
- 判读差异导致临床管理改变18/252例(7.1%,95%CI 4.0%-10.2%),其中手术管理改变15/252例(6.0%,95%CI 3.0%-8.9%)。
- 发现额外恶性肿瘤或更大范围病变11/252例(4.4%,95%CI 1.8%-6.9%)。
临床应用与阅片要点
- 对乳腺癌患者院外乳腺影像进行亚专科二次会诊判读可发现显著差异,并常导致额外检查、治疗计划改变及新恶性肿瘤的发现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess the incidence and clinical significance of discrepancy in subspecialty interpretation of outside breast imaging examinations for newly diagnosed breast cancer patients presenting to a tertiary cancer center.
MATERIALS AND METHODS: This Institutional Review Board-approved retrospective study included patients presenting from July 2016 to March 2017 to a National Cancer Institute-designated comprehensive cancer center for second opinion after breast cancer diagnosis. Outside and second opinion radiology reports of 252 randomly selected patients were compared by two subspecialty breast radiologists to consensus. A peer review score was assigned, modeled after ACR's RADPEERTM peer review metric: 1-agree; 2-minor discrepancy (unlikely clinically significant); 3-moderate discrepancy (may be clinically significant); 4-major discrepancy (likely clinically significant). Among cases with clinically significant discrepancies, rates of clinical management change (management alterations including change in follow-up, neoadjuvant therapy use, and surgical management as a direct result of image review), and detection of additional malignancy were assessed through electronic medical record review.
RESULTS: A significant difference in interpretation (scores = 3 or 4) was seen in 41 of 252 cases (16%, 95% confidence interval [CI], 11.7%-20.8%). The difference led to additional workup in 38 of 252 cases (15%, 95% CI 10.6%-19.5%) and change in clinical management in 18 of 252 cases (7.1%, 95% CI 4.0%-10.2%), including 15 of 252 with change in surgical management (6.0%, 95% CI, 3.0%-8.9%). An additional malignancy or larger area of disease was identified in 11 of 252 cases (4.4%, 95% CI, 1.8%-6.9%).
CONCLUSION: Discrepancy between outside and second-opinion breast imaging subspecialists frequently results in additional workup for breast cancer patients, changes in treatment plan, and identification of new malignancies.
引用
- Whorms DS, Giess CS, Golshan M, et al. Clinical Impact of Second Opinion Radiology Consultation for Patients With Breast Cancer. J Am Coll Radiol. 2018. PMID: 30579707. doi:10.1016/j.jacr.2018.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。